These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33156525)

  • 1. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
    Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
    Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.
    Friedrich R; Rappold E; Bogdan C; Held J
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29899003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.
    De Carolis E; Marchionni F; Torelli R; Angela MG; Pagano L; Murri R; De Pascale G; De Angelis G; Sanguinetti M; Posteraro B
    PLoS One; 2020; 15(7):e0236095. PubMed ID: 32726358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.
    White SK; Schmidt RL; Walker BS; Hanson KE
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009833. PubMed ID: 32693433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying optimal serum 1,3-β-D-Glucan cut-off for diagnosing Pneumocystis Jirovecii Pneumonia in non-HIV patients in the intensive care unit.
    Li YY; Chen Y; Li S; Dong R; Yang QW; Peng JM; Du B
    BMC Infect Dis; 2024 Sep; 24(1):1015. PubMed ID: 39304817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children.
    Calitri C; Caviglia I; Cangemi G; Furfaro E; Bandettini R; Fioredda F; Amoroso L; Faraci M; Risso FM; Mattioli G; Moscatelli A; Haupt R; Castagnola E
    Mycoses; 2017 Dec; 60(12):789-795. PubMed ID: 28833726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of the (1-3)-β-d-glucan assay in patients with different risks for invasive fungal diseases.
    Nham E; Kim SH; Ko JH; Huh K; Cho SY; Kang CI; Chung DR; Peck KR
    Med Mycol; 2024 Aug; 62(8):. PubMed ID: 39030069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.
    Lahmer T; Held J; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Dec; 181(11-12):815-821. PubMed ID: 27619810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-d-Glucan for Diagnosing
    Mercier T; Guldentops E; Patteet S; Beuselinck K; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30918045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
    Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
    Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a Turbidimetric β-d-Glucan Test for Detection of Pneumocystis jirovecii Pneumonia.
    Dichtl K; Seybold U; Wagener J
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29720434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of Pneumocystis jirovecii in clinical specimens by different methods].
    Tekinşen FF; Koç AN
    Mikrobiyol Bul; 2013 Oct; 47(4):658-67. PubMed ID: 24237434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
    Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
    Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two β-D-glucan assays for detecting invasive fungal diseases in immunocompromised patients.
    Song J; Kim S; Park J; Park Y; Kim HS
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115415. PubMed ID: 34082306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of Pneumocystis pneumonia.
    White PL; Posso RB; Gorton RL; Price JS; Wey E; Barnes RA
    Med Mycol; 2018 Aug; 56(6):778-781. PubMed ID: 29087494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
    Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
    Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What should be the optimal cut-off of serum 1,3-β-D-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?
    Metan G; Koç AN; Atalay A; Kaynar LG; Ozturk A; Alp E; Eser B
    Scand J Infect Dis; 2012 May; 44(5):330-6. PubMed ID: 22188426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
    Otto WR; Dvorak CC; Boge CLK; Ostrosky-Zeichner L; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L; Fisher BT
    Pediatr Transplant; 2023 Feb; 27(1):e14399. PubMed ID: 36299233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Performance of the Associates of Cape Cod STAT Assay for the Diagnosis of Invasive Fungal Disease in Critical-Care Patients with COVID-19.
    White PL; Price JS; Backx M
    J Clin Microbiol; 2021 Aug; 59(9):e0086921. PubMed ID: 34190576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.